Werner Hacke

25.0k total citations · 5 hit papers
117 papers, 14.3k citations indexed

About

Werner Hacke is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Werner Hacke has authored 117 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Cardiology and Cardiovascular Medicine, 34 papers in Internal Medicine and 30 papers in Epidemiology. Recurrent topics in Werner Hacke's work include Atrial Fibrillation Management and Outcomes (76 papers), Venous Thromboembolism Diagnosis and Management (34 papers) and Cardiac Arrhythmias and Treatments (32 papers). Werner Hacke is often cited by papers focused on Atrial Fibrillation Management and Outcomes (76 papers), Venous Thromboembolism Diagnosis and Management (34 papers) and Cardiac Arrhythmias and Treatments (32 papers). Werner Hacke collaborates with scholars based in Germany, United States and United Kingdom. Werner Hacke's co-authors include Keith A.A. Fox, Graeme J. Hankey, Daniel E. Singer, Manesh R. Patel, Kenneth W. Mahaffey, Günter Breithardt, Christopher C. Nessel, Jonathan L. Halperin, Jonathan P. Piccini and Richard C. Becker and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Werner Hacke

113 papers receiving 13.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

2011 6.6k citations Manesh R. Patel, Kenneth W. Mahaffey et al. profile →
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

2015 745 citations Hein Heidbüchel, Peter Verhamme et al. EP Europace profile →
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

2013 570 citations Hein Heidbüchel, Peter Verhamme et al. EP Europace profile →
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry

2013 343 citations Ajay K. Kakkar, Jean‐Pierre Bassand et al. profile →
Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

2014 321 citations Jonathan L. Halperin, Graeme J. Hankey et al. Circulation profile →

Peers

Countries citing papers authored by Werner Hacke

Since Specialization

Citations

This map shows the geographic impact of Werner Hacke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Hacke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Hacke more than expected).

Fields of papers citing papers by Werner Hacke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Hacke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Hacke. The network helps show where Werner Hacke may publish in the future.

Co-authorship network of co-authors of Werner Hacke

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Hacke. A scholar is included among the top collaborators of Werner Hacke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Hacke. Werner Hacke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD‐AF registry 2023 ·Diabetes Obesity and Metabolism ·Jean‐Pierre Bassand, Saverio Virdone, A. John Camm, Keith A.A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, Mátyás Keltai, Frank Misselwitz, Karen S. Pieper, Alexander G.G. Turpie, Freek W.A. Verheugt, Ajay K. Kakkar, (unknown)	1
2	Implementing the proclamation of stroke and potentially preventable dementias 2018 ·Journal of Clinical Hypertension ·Vladimir Hachinski, Detlev Ganten, Daniel T. Lackland, Reinhold Kreutz, Konstantinos Tsioufis, Werner Hacke	1
3	Implementing the Proclamation of Stroke and Potentially Preventable Dementias 2018 ·International Journal of Stroke ·Vladimir Hachinski, Detlev Ganten, Daniel T. Lackland, Reinhold Kreutz, Konstantinos Tsioufis, Werner Hacke	9
4	Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AF 2018 ·American Heart Journal ·Sean T. Chen, Anne S. Hellkamp, Richard C. Becker, Scott D. Berkowitz, Günter Breithardt, Keith A.A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Kenneth W. Mahaffey, Christopher C. Nessel, Jonathan P. Piccini, Daniel E. Singer, Manesh R. Patel	5
5	Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation 2017 ·BMJ Open ·Keith A.A. Fox, Joseph E. Lucas, Karen S. Pieper, Jean‐Pierre Bassand, A. John Camm, David Fitzmaurice, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, Ali̇ Oto, LG Mantovani, Frank Misselwitz, Jonathan P. Piccini, Alexander G.G. Turpie, Freek W.A. Verheugt, Ajay K. Kakkar	88
6	Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary 2016 ·European Heart Journal ·Hein Heidbüchel, Peter Verhamme, Marco Alings, Matthias Antz, Hans‐Christoph Diener, Werner Hacke, Jonas Oldgren, Peter Sinnaeve, A. John Camm, Paulus Kirchhof	188
7	Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF 2016 ·European Heart Journal ·Jean‐Pierre Bassand, Gabriele Accetta, Alan John Camm, Frank Cools, David Fitzmaurice, Keith A.A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, LG Mantovani, Frank Misselwitz, Hugo Ten Cate, Alexander G.G. Turpie, Freek W.A. Verheugt, Ajay K. Kakkar	196
8	Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation breakdown → 2015 ·EP Europace ·Hein Heidbüchel, Peter Verhamme, Marco Alings, Matthias Antz, Hans‐Christoph Diener, Werner Hacke, Jonas Oldgren, Peter Sinnaeve, A. John Camm, Paulus Kirchhof	745
9	OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL 2014 ·Journal of the American College of Cardiology ·(unknown), Derek D. Cyr, Yuliya Lokhnygina, Richard C. Becker, Scott D. Berkowitz, G Breithardt, Robert M. Califf, Keith A.A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Kenneth W. Mahaffey, Christopher C. Nessel, Jonathan P. Piccini, Daniel E. Singer, Manesh R. Patel	2
10	Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: Results from the ROCKET AF trial 2014 ·Heart Rhythm ·Benjamin A. Steinberg, Anne S. Hellkamp, Yuliya Lokhnygina, Jonathan L. Halperin, Günter Breithardt, Rod Passman, Graeme J. Hankey, Manesh R. Patel, Richard C. Becker, Daniel E. Singer, Werner Hacke, Scott D. Berkowitz, Christopher C. Nessel, Kenneth W. Mahaffey, Keith A.A. Fox, Robert M. Califf, Jonathan P. Piccini	55
11	Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial 2014 ·European Heart Journal ·Benjamin A. Steinberg, Anne S. Hellkamp, Yuliya Lokhnygina, Manesh R. Patel, Günter Breithardt, Graeme J. Hankey, Rüdiger Becker, Daniel E. Singer, Jonathan L. Halperin, Werner Hacke, Christopher C. Nessel, Scott D. Berkowitz, Kenneth W. Mahaffey, Keith A.A. Fox, Robert M. Califf, Jonathan P. Piccini	237
12	Efficacy and Safety of Rivaroxaban in Patients With Heart Failure and Nonvalvular Atrial Fibrillation 2013 ·Circulation Heart Failure ·Sean van Diepen, Anne S. Hellkamp, Manesh R. Patel, Richard C. Becker, Günter Breithardt, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Scott D. Berkowitz, Robert M. Califf, Keith A.A. Fox, Kenneth W. Mahaffey	83
13	Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial 2013 ·Journal of the American College of Cardiology ·Jonathan P. Piccini, Susanna R. Stevens, Yuliya Lokhnygina, Manesh R. Patel, Jonathan L. Halperin, Daniel E. Singer, Graeme J. Hankey, Werner Hacke, Richard C. Becker, Christopher C. Nessel, Kenneth W. Mahaffey, Keith A.A. Fox, Robert M. Califf, Günter Breithardt	207
14	Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation 2012 ·Circulation ·Jonathan P. Piccini, Susanna R. Stevens, Yuchiao Chang, Daniel E. Singer, Yuliya Lokhnygina, Alan S. Go, Manesh R. Patel, Kenneth W. Mahaffey, Jonathan L. Halperin, Günter Breithardt, Graeme J. Hankey, Werner Hacke, Richard C. Becker, Christopher C. Nessel, Keith A.A. Fox, Robert M. Califf	375
15	Abstract 19281: Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial 2012 ·Circulation ·Jonathan P. Piccini, Susanna R. Stevens, Yuliya Lokhnygina, Manesh R. Patel, Daniel E. Singer, Jonathan L. Halperin, Graeme J. Hankey, Werner Hacke, Richard C. Becker, Christopher C. Nessel, Kenneth W. Mahaffey, Keith A.A. Fox, (unknown), Günter Breithardt	6
16	Abstract 15544: Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Subgroup Analysis of the ROCKET AF Trial 2012 ·Circulation ·Jonathan L. Halperin, Zachary T. Bloomgarden, Anne S. Hellkamp, Yuliya Lokhnygina, Manesh R. Patel, Richard C. Becker, Günter Breithardt, Werner Hacke, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Scott D. Berkowitz, Robert M. Califf, Keith A.A. Fox, Kenneth W. Mahaffey	4
17	Abstract 13482: Ischemic Cardiac Outcomes in Patients with AF Treated with Vitamin K Antagonism or Factor Xa Inhibition: Results from the ROCKET AF Trial 2011 ·Circulation ·Kenneth W. Mahaffey, Harvey D. White, Christopher C. Nessel, Shaun G. Goodman, Jonathan Piccini, Manesh R. Patel, John F. Paolini, Richard C. Becker, Jonathan L. Halperin, Werner Hacke, Daniel E. Singer, Graeme J. Hankey, Robert M. Califf, Keith A.A. Fox, Günter Breithardt	3
18	Intrapulmonary Right-Left Shunts in Guillain-Barré Syndrome with Severe Dysautonomia 2008 ·Neurocritical Care ·M. Sýkora, Jennifer Diedler, Werner Hacke, Roland Veltkamp	3
19	Hemicraniotomy in Space-Occupying Hemispheric Infarction: Useful Early Intervention or Desperate Activism? 1996 ·Cerebrovascular Diseases ·Stefan Schwab, K. Rieke, Alfred Aschoff, Friedrich K. Albert, Rüdiger von Kummer, Werner Hacke	25
20	[Therapeutic hypothermia after cerebral ischemia. Theoretical principles and possible clinical applications]. 1994 ·PubMed ·Stefan Schwab, Markus Horn, Matthias Spranger, Werner Hacke	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact